CNBC 快讯 4月6日 16:56 FDA拒绝发布外国药品进口具体指引——监管灰色地带持续压低品牌药企风险溢价 FDA declines to issue specific guidance on health programs' foreign drug imports A CNBC investigation revealed the proliferation of AFPs, which import prescription drugs from overseas in what U.S. regu… FG 100 读报告 →